Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential
TipRanksApr 3 03:45
Femasys Analyst Ratings
BenzingaApr 1 18:41
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12
BenzingaApr 1 18:43
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)
TipRanksMar 22 02:30
Femasys Analyst Ratings
BenzingaMar 22 00:52
Chardan Capital Reiterates Buy on Femasys, Maintains $12 Price Target
BenzingaMar 22 00:54
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
TipRanksMar 21 18:31
Femasys Analyst Ratings
BenzingaMar 21 18:28
HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $10 Price Target
BenzingaMar 21 18:29
Femasys (FEMY): Solid Financials and Promising Product Developments Reinforce Buy Rating
TipRanksNov 16, 2023 01:35
Promising Financial and Clinical Prospects Propel Femasys to a 'Buy' Rating by Chardan Capital
TipRanksNov 15, 2023 10:45
Femasys Analyst Ratings
BenzingaNov 15, 2023 00:18
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BerGenBio AS (BRRGF)
TipRanksNov 14, 2023 23:50
Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Femasys (FEMY)
TipRanksNov 14, 2023 23:40
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $13
BenzingaSep 29, 2023 18:26
Femasys Analyst Ratings
BenzingaSep 29, 2023 18:25
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Femasys (FEMY) and ImmunoGen (IMGN)
TipRanksSep 29, 2023 18:20
Analysts Offer Insights on Healthcare Companies: Organogenesis Holdings (ORGO) and Femasys (FEMY)
TipRanksSep 28, 2023 19:40
JonesTrading Maintains Buy on Femasys, Raises Price Target to $7
BenzingaSep 26, 2023 22:10
Femasys Analyst Ratings
BenzingaSep 26, 2023 22:05
No Data
No Data